For media enquiries or more information about Communications at the 
Djavad Mowafaghian Centre for Brain Health, please contact:

Emily Wight, Communications Manager
Email: | Phone: 604.827.3396

CARD 2016 Alzheimer Update participant with iClicker
Patient collaboration in research leads to meaningful outcomes Jul 8, 2016

Dr. Julie Robillard believes that good research puts patients first. In the labs and clinics of the Djavad Mowafaghian Centre for Brain Health, she has been working hard to improve communication between researchers and the people who could most benefit from their work and to integrate patients into research from the beginning, at every stage from study design to communication of results.

Researchers tackle non-adherence to MS medication in new study Jul 6, 2016

For some patients with multiple sclerosis (MS), adhering to a strict disease-modifying therapy (DMT) regimen can be challenging. Some DMTs for the treatment of relapsing-remitting MS are injectable and require long-term use, so it’s understandable that some patients may not adhere well to these treatments. Kyla McKay, PhD candidate and epidemiology researcher with Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group, set out to discover why.

Dr. Max Cynader appointed to CIHR College of Reviewers Jun 17, 2016

Dr. Max Cynader has been appointed to a Chair in the Canadian Institutes for Health Research (CIHR) College of Reviewers, a new program that will serve CIHR and its stakeholders by bringing together a diverse cohort of researchers to enhance the quality of the peer review process.

CERC Spotlight on Dr. Matthew Farrer Jun 16, 2016

When he joined The University of British Columbia (UBC) in 2010 as Canada Excellence Research Chair (CERC) in Neurogenetics and Translational Neuroscience, Dr. Matthew Farrer arrived with the reputation of having made some of the most significant contributions to Parkinson’s disease research over the previous decade.

Carles Vilarino-Guell
Researchers find genetic cause of multiple sclerosis Jun 1, 2016

The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.

Older man thinking
Newly discovered biomarker offers genetic predictor of dementia in Parkinson disease May 24, 2016

For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.

Circle of young children
Gut microbes associated with early onset pediatric MS May 16, 2016

Bacteria in the guts of children who had recently developed multiple sclerosis (MS) differed from healthy control children, finds new research from Dr. Helen Tremlett and her University of California research colleagues, including co-PI Dr. Emmanuelle Waubant. These differences were suggestive of a pro-inflammatory environment within the gut bacterial community of the children with MS.

Trainee Profile: Dr. Simon Chen Apr 21, 2016

"In Dr. Haas’ lab, we identified the involvement of the transcription factor MEF2 in regulating metaplasticity by accident. The finding was totally unexpected," says Dr. Simon Chen, who completed his PhD in Dr. Kurt Haas’ lab at UBC. Dr. Chen is currently finishing up his postdoctoral work at the University of California, San Diego, before heading to the University of Ottawa where he will take up a Canada Research Chair in Neural Circuits and Behavior.

UBC showcases its strengths as neurologists meet in Vancouver Apr 14, 2016

As 12,000 neurologists descend on Vancouver for the American Academy of Neurology’s 68th annual meeting this week, the Djavad Mowafaghian Centre for Brain Health is poised to make the most of the opportunity to showcase our clinical and scientific leadership in the field.

Three Centre members will be giving talks at plenary sessions the world’s largest gathering of neurologists, taking place at the Vancouver Convention Centre April 15-21: